What topical cream should be used for red, itchy skin between the eyebrows?

Topical Hydrocortisone Cream for Red, Itchy Skin Between the Eyebrows

For red, itchy skin between the eyebrows, start with a low-potency topical corticosteroid such as hydrocortisone 2.5% cream applied to the affected area, combined with a fragrance-free moisturizer. This presentation is most consistent with either seborrheic dermatitis or mild atopic dermatitis affecting the glabella region.

Initial Treatment Approach

The area between the eyebrows is a common site for inflammatory dermatoses, particularly seborrheic dermatitis. Based on the most recent atopic dermatitis guidelines 1, topical corticosteroids are strongly recommended as first-line therapy for inflammatory skin conditions with high certainty evidence. For facial application, lower-potency steroids are preferred to minimize adverse effects.

Specific Cream Recommendations:

• Hydrocortisone 2.5% cream (Class V/VI corticosteroid) 2

  • Apply twice daily to affected area
  • Safe for facial use
  • Minimal risk of skin atrophy with short-term use

• Alternative if no improvement in 2 weeks: Consider pimecrolimus 1% cream 1

  • Calcineurin inhibitor with strong recommendation for mild-to-moderate inflammatory dermatitis
  • Particularly useful for facial application where steroid side effects are a concern
  • May cause temporary burning/stinging initially 3, 4, 5

Adjunctive Measures

Essential supportive care 1:

• Apply fragrance-free, urea- or glycerin-based moisturizer 6
• Avoid alcohol-containing products 6
• Use gentle, soap-free cleansers 6

For pruritus control 6:

• Oral antihistamines: cetirizine 10 mg daily or loratadine 10 mg daily (non-sedating)
• Alternative: hydroxyzine 10-25 mg at bedtime if sleep disruption occurs

Treatment Algorithm

1. Week 0-2: Hydrocortisone 2.5% cream twice daily + moisturizer

   • If excellent response: taper to once daily, then as needed

2. Week 2 reassessment 6:

   • If improved: Continue current regimen, consider maintenance therapy
   • If no improvement or worsening:
     • Switch to pimecrolimus 1% cream twice daily, OR
     • Consider moderate-potency steroid (prednicarbate 0.02% cream) for short-term use 6
     • Refer to dermatologist if no response

3. Week 4: If still no improvement, dermatology referral indicated

Important Caveats

Avoid prolonged continuous use of topical corticosteroids on the face 1. While short-term use (median 3 weeks) shows no evidence of skin thinning 7, longer-term continuous use increases this risk. The evidence shows intermittent maintenance therapy (2 times per week) is effective for preventing flares with low adverse event rates 1.

For seborrheic dermatitis specifically (if this is the underlying diagnosis), pimecrolimus 1% cream has demonstrated effectiveness with favorable long-term safety profiles 3, 4, 5, making it an excellent steroid-sparing option for this facial location.

Red flags requiring immediate dermatology referral:

• Symptoms covering >30% body surface area
• Signs of secondary infection (crusting, weeping, pustules)
• No response to appropriate topical therapy after 4 weeks
• Severe symptoms affecting quality of life or sleep

The facial location makes this a priority for using the lowest effective potency steroid to achieve control, then transitioning to maintenance strategies or steroid-sparing agents like pimecrolimus to minimize long-term complications.